Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading

ObjectivesTo investigate the value of contrast-enhanced computer tomography (CT)-based on radiomics in discriminating high-grade and low-grade hepatocellular carcinoma (HCC) before surgery.MethodsThe retrospective study including 161 consecutive subjects with HCC which was approved by the institutio...

Full description

Bibliographic Details
Main Authors: Wen Chen, Tao Zhang, Lin Xu, Liang Zhao, Huan Liu, Liang Rui Gu, Dai Zhong Wang, Ming Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.660509/full
id doaj-462c2ae2590d4590a75eb25a9b9c6516
record_format Article
spelling doaj-462c2ae2590d4590a75eb25a9b9c65162021-06-04T13:57:23ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-06-011110.3389/fonc.2021.660509660509Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma GradingWen Chen0Wen Chen1Tao Zhang2Lin Xu3Liang Zhao4Huan Liu5Liang Rui Gu6Dai Zhong Wang7Ming Zhang8Department of Medical Imaging, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Radiology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaPrecision Medicine Research Center, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaGE Healthcare, Shanghai, ChinaDepartment of Radiology, Shanghai Sixth People’s Hospital, Shanghai, ChinaDepartment of Pathology, Taihe Hospital, Hubei University of Medicine, Shiyan, ChinaDepartment of Medical Imaging, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaObjectivesTo investigate the value of contrast-enhanced computer tomography (CT)-based on radiomics in discriminating high-grade and low-grade hepatocellular carcinoma (HCC) before surgery.MethodsThe retrospective study including 161 consecutive subjects with HCC which was approved by the institutional review board, and the patients were divided into a training group (n = 112) and test group (n = 49) from January 2013 to January 2018. The least absolute shrinkage and selection operator (LASSO) was used to select the most valuable features to build a support vector machine (SVM) model. The performance of the predictive model was evaluated using the area under the curve (AUC), accuracy, sensitivity, and specificity.ResultsThe SVM model showed an acceptable ability to differentiate high-grade from low-grade HCC, with an AUC of 0.904 in the training dataset and 0.937 in the test dataset, accuracy (92.2% versus 95.7%), sensitivity(82.5% versus 88.0%), and specificity (92.7% versus 95.8%), respectively.ConclusionThe machine learning-based radiomics reflects a better evaluating performance in differentiating HCC between low-grade and high-grade, which may contribute to personalized treatment.https://www.frontiersin.org/articles/10.3389/fonc.2021.660509/fullradiomicsmachine learningsupport vector machinehepatocellular carcinomagrading
collection DOAJ
language English
format Article
sources DOAJ
author Wen Chen
Wen Chen
Tao Zhang
Lin Xu
Liang Zhao
Huan Liu
Liang Rui Gu
Dai Zhong Wang
Ming Zhang
spellingShingle Wen Chen
Wen Chen
Tao Zhang
Lin Xu
Liang Zhao
Huan Liu
Liang Rui Gu
Dai Zhong Wang
Ming Zhang
Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
Frontiers in Oncology
radiomics
machine learning
support vector machine
hepatocellular carcinoma
grading
author_facet Wen Chen
Wen Chen
Tao Zhang
Lin Xu
Liang Zhao
Huan Liu
Liang Rui Gu
Dai Zhong Wang
Ming Zhang
author_sort Wen Chen
title Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
title_short Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
title_full Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
title_fullStr Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
title_full_unstemmed Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading
title_sort radiomics analysis of contrast-enhanced ct for hepatocellular carcinoma grading
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-06-01
description ObjectivesTo investigate the value of contrast-enhanced computer tomography (CT)-based on radiomics in discriminating high-grade and low-grade hepatocellular carcinoma (HCC) before surgery.MethodsThe retrospective study including 161 consecutive subjects with HCC which was approved by the institutional review board, and the patients were divided into a training group (n = 112) and test group (n = 49) from January 2013 to January 2018. The least absolute shrinkage and selection operator (LASSO) was used to select the most valuable features to build a support vector machine (SVM) model. The performance of the predictive model was evaluated using the area under the curve (AUC), accuracy, sensitivity, and specificity.ResultsThe SVM model showed an acceptable ability to differentiate high-grade from low-grade HCC, with an AUC of 0.904 in the training dataset and 0.937 in the test dataset, accuracy (92.2% versus 95.7%), sensitivity(82.5% versus 88.0%), and specificity (92.7% versus 95.8%), respectively.ConclusionThe machine learning-based radiomics reflects a better evaluating performance in differentiating HCC between low-grade and high-grade, which may contribute to personalized treatment.
topic radiomics
machine learning
support vector machine
hepatocellular carcinoma
grading
url https://www.frontiersin.org/articles/10.3389/fonc.2021.660509/full
work_keys_str_mv AT wenchen radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT wenchen radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT taozhang radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT linxu radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT liangzhao radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT huanliu radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT liangruigu radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT daizhongwang radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
AT mingzhang radiomicsanalysisofcontrastenhancedctforhepatocellularcarcinomagrading
_version_ 1721397462296428544